FDA committee endorses omicron-targeting Covid booster strategy


A key advisory committee to the FDA has voted overwhelmingly in favor of updated Covid-19 vaccines that target the omicron variant, paving the way for manufacturers including Cambridge's Moderna Inc. to move ahead with their shots.

Previous HM Insurance Group, United Concordia Dental fund scholarships
Next Hernando Hide-A-Way's owners to take show on the road